US Stock MarketDetailed Quotes
CAH Cardinal Health
- 102.170
- -0.870-0.84%
Close May 1 16:00 ET
- 102.140
- -0.030-0.03%
Post 18:57 ET
24.85BMarket Cap40.54P/E (TTM)
103.100High100.560Low2.86MVolume102.250Open103.040Pre Close292.47MTurnover1.18%Turnover Ratio102.17P/E (Static)243.23MShares115.52452wk High-7.21P/B24.72BFloat Cap79.24952wk Low2.00Dividend TTM241.94MShs Float115.524Historical High1.96%Div YieldTTM2.47%Amplitude14.678Historical Low102.302Avg Price1Lot Size
Cardinal Health Key Stats
Quarterly+Annual
YOY
| (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (Q3)Mar 31, 2023 | (Q2)Dec 31, 2022 | (Q1)Sep 30, 2022 | (FY)Jun 30, 2022 | (Q4)Jun 30, 2022 | (Q3)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 99.16%1.19B | 2,269.57%545M | -9.06%2.84B | -71.32%858M | 424.82%1.36B | -50.04%597M | 103.56%23M | 28.53%3.12B | 349.92%2.99B | -251.26%-419M |
| Net income from continuing operations | 372.31%354M | -94.59%6M | 128.11%262M | -148.18%-66M | 124.96%347M | -365.31%-130M | -59.19%111M | -252.29%-932M | 19.13%137M | -1,258.33%-1.39B |
| Operating gains losses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -50.00%8M | --0 | ---1M |
| Depreciation and amortization | 2.94%175M | 0.58%172M | 0.00%692M | -1.68%176M | -3.31%175M | 3.66%170M | 1.79%171M | -11.62%692M | -0.56%179M | -9.05%181M |
| Deferred tax | ---- | ---- | -542.86%-31M | ---- | ---- | ---- | ---- | -98.59%7M | ---- | ---- |
| Change In working capital | 396.63%617M | 50.86%-228M | -58.72%464M | -84.60%358M | 184.98%778M | 39.36%-208M | 58.94%-464M | 288.93%1.12B | 1,525.77%2.32B | 272.78%273M |
| -Change in receivables | -30.66%-537M | 109.84%50M | 37.94%-947M | -31.23%-437M | 147.34%409M | -257.39%-411M | -137.38%-508M | -68.81%-1.53B | 15.27%-333M | -7,100.00%-864M |
| -Change in inventory | -7.25%-1.48B | -300.38%-1.06B | 68.25%-340M | 551.01%672M | 212.48%631M | -494.40%-1.38B | -104.65%-264M | 32.39%-1.07B | 42.91%-149M | -737.31%-561M |
| -Change in payables and accrued expense | 66.43%2.63B | 152.92%779M | -52.94%1.75B | -95.62%123M | -115.43%-262M | 39,450.00%1.58B | 139.14%308M | 33.99%3.72B | 471.49%2.81B | 2,249.37%1.7B |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 99.16%1.19B | 2,269.57%545M | -9.06%2.84B | -71.32%858M | 424.82%1.36B | -50.04%597M | 103.56%23M | 28.53%3.12B | 349.92%2.99B | -251.26%-419M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -20.69%-105M | 10.00%-63M | -180.07%-454M | -0.98%-206M | -106.82%-91M | -85.11%-87M | -108.12%-70M | 250.00%567M | -131.82%-204M | 55.56%-44M |
| Net PPE purchase and sale | -32.94%-113M | -33.82%-91M | -31.74%-469M | -43.75%-207M | 89.20%-109M | -109.84%-85M | -1.49%-68M | 11.00%-356M | -14.29%-144M | -909.00%-1.01B |
| Net business purchase and sale | ---- | ---- | -101.11%-10M | --0 | -101.08%-10M | ---- | ---- | 30,133.33%901M | ---22M | --923M |
| Net investment purchase and sale | 50.00%-1M | 1,500.00%28M | 13.64%25M | 102.63%1M | -33.33%28M | -112.50%-2M | -200.00%-2M | -12.00%22M | -200.00%-38M | 4,100.00%42M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -20.69%-105M | 10.00%-63M | -180.07%-454M | -0.98%-206M | -106.82%-91M | -85.11%-87M | -108.12%-70M | 250.00%567M | -131.82%-204M | 55.56%-44M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 2.49%-353M | 42.73%-666M | -23.87%-3.05B | -42.65%-592M | -174.71%-934M | 18.47%-362M | 7.99%-1.16B | -87.02%-2.46B | 36.06%-415M | -4.94%-340M |
| Net issuance payments of debt | -33.33%-8M | 0.00%-7M | 34.58%-579M | 97.22%-8M | -11,060.00%-558M | -20.00%-6M | 98.81%-7M | -55.26%-885M | 44.29%-288M | -25.00%-5M |
| Net common stock issuance | 0.00%-250M | 50.00%-500M | -100.00%-2B | ---500M | -25.00%-250M | 16.67%-250M | -100.00%-1B | -400.00%-1B | --0 | 0.00%-200M |
| Cash dividends paid | 3.88%-124M | 7.75%-131M | 6.08%-525M | 5.97%-126M | 5.88%-128M | 7.86%-129M | 4.70%-142M | 2.44%-559M | 4.96%-134M | 4.90%-136M |
| Net other financing activities | 26.09%29M | -100.00%-28M | 378.95%53M | 500.00%42M | 100.00%2M | 2,200.00%23M | 50.00%-14M | -173.08%-19M | -22.22%7M | -95.65%1M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 2.49%-353M | 42.73%-666M | -23.87%-3.05B | -42.65%-592M | -174.71%-934M | 18.47%-362M | 7.99%-1.16B | -87.02%-2.46B | 36.06%-415M | -4.94%-340M |
| Net cash flow | ||||||||||
| Beginning cash position | 10.37%3.85B | -14.29%4.04B | 38.45%4.72B | 69.35%3.99B | 15.60%3.65B | 41.78%3.49B | 38.45%4.72B | 22.95%3.41B | -32.67%2.36B | -15.41%3.16B |
| Current changes in cash | 393.92%731M | 84.79%-184M | -154.32%-666M | -97.47%60M | 141.84%336M | -78.98%148M | -15.46%-1.21B | 67.03%1.23B | 3,395.83%2.37B | -450.00%-803M |
| Effect of exchange rate changes | -57.14%6M | 66.67%-5M | 68.00%-8M | 41.67%-7M | --0 | 333.33%14M | -200.00%-15M | -327.27%-25M | -500.00%-12M | 66.67%-2M |
| End cash Position | 25.64%4.59B | 10.37%3.85B | -14.29%4.04B | -14.29%4.04B | 69.35%3.99B | 15.60%3.65B | 41.78%3.49B | 38.45%4.72B | 38.45%4.72B | -32.67%2.36B |
| Free cash flow | 109.96%1.08B | 1,063.83%453M | -13.78%2.36B | -77.33%641M | 349.90%1.25B | -54.33%512M | 93.41%-47M | 34.80%2.74B | 424.68%2.83B | -383.05%-501M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg